Nachrichten zur Vertex Pharmaceuticals Inc. Aktie

Forget Tesla, Buy This Magnificent Healthcare Stock Instead

Vertex Pharmaceuticals already has a fantastic business, and it could get much bigger in the future.…

5 Small Biotech ETFs to Watch (Updated 2024)

Thanks to exchange-traded funds (ETFs), investors don’t have to be tied to one specific stock. Biotech ETFs allow market participants…

3 Reasons to Buy Vertex Pharmaceuticals Stock Like Theres No Tomorrow

Vertex shares have climbed almost 50% over the past year.…

3 Reasons to Buy Vertex Pharmaceuticals Stock Like Theres No Tomorrow @themotleyfool #stocks $VRTX $CRSP

Vertex shares have climbed almost 50% over the past year.…

The Zacks Analyst Blog Highlights JPMorgan Chase, Salesforce, Vertex Pharmaceuticals, Palo Alto Networks and The Williams Companies

JPMorgan Chase, Salesforce, Vertex Pharmaceuticals, Palo Alto Networks and The Williams Companies are part of the Zacks top Analyst Blog.…

Vertex Pharmaceuticals Is About to Extend Its Leadership in This Billion-Dollar Market @themotleyfool #stocks $VRTX

Vertexs main business may be heading for a new era of growth...…

Vertex Pharmaceuticals Is About to Extend Its Leadership in This Billion-Dollar Market

Vertexs main business may be heading for a new era of growth...…

Vertex Pharmaceuticals Will Use $100 Million to Tank Its Own Market Share. Heres Why Thats a Smart Move.

Sometimes, the winning move doesnt look right at first.…

Vertex Pharmaceuticals Will Use $100 Million to Tank Its Own Market Share. Heres Why Thats a Smart Move.

…

Stock-Split Watch: Is Vertex Pharmaceuticals Next? @themotleyfool #stocks $VRTX

Its on track to launch more blockbuster drugs.…

Stock-Split Watch: Is Vertex Pharmaceuticals Next?

Its on track to launch more blockbuster drugs.…

If You Invested $10,000 in Vertex Pharmaceuticals in 2014, This Is How Much You Would Have Today

You cant go back in the past, but its not too late to invest in this top stock.…

New CRISPR Gene-Editing Treatment Approved In Europe For Inherited Blood Disorders

The decision comes after Vertex Pharmaceuticals and CRISPR Therapeutics’ Casgevy was approved in the UK and US for sickle cell…

Analyst Report: Vertex Pharmaceuticals, Inc.

…

Is Vertex Pharmaceuticals Stock a Buy Now?

The company just released its latest earnings report, and growth investors may be a little disappointed.…

Is Vertex Pharmaceuticals Stock a Buy Now? @themotleyfool #stocks $VRTX

The company just released its latest earnings report, and growth investors may be a little disappointed.…

Could Vertex Pharmaceuticals Reach $500 in 2024?

Vertex shares have several catalysts on the horizon...…

Could Vertex Pharmaceuticals Reach $500 in 2024? @themotleyfool #stocks $VRTX

Vertex shares have several catalysts on the horizon...…

Vertex Pharmaceuticals Has a $10 Billion Opportunity on the Table. Heres How You Can Invest @themotleyfool #stocks $VRTX

Its foray into developing analgesics seems to be going swimmingly.…

Vertex Pharmaceuticals Has a $10 Billion Opportunity on the Table. Heres How You Can Invest

Its foray into developing analgesics seems to be going swimmingly.…

Futures Dip; Palantir Soars On Surging AI Demand

Other key earnings movers include Eli Lilly, Spotify and Vertex Pharmaceuticals.…

Vertex Pharmaceuticals: Gute Q4-Zahlen - Das nächste Mukoviszidose-Mittel steht in den Startlöchern - Aktienanalyse

Kulmbach (www.aktiencheck.de) - Vertex Pharmaceuticals-Aktienanalyse von "Der Aktionär": Michel Doepke vom Anlegermagazin "Der Aktionär" nimmt in einer aktuellen Aktienanalyse die Aktie…

Vertex Pharmaceuticals (VRTX) Q4 2023 Earnings Call Transcript

VRTX earnings call for the period ending December 31, 2023.…

Vertex Pharmaceuticals Incorporated 2023 Q4 - Results - Earnings Call Presentation

…

Vertex Pharmaceuticals May Be About to Solve a Common Health Problem. Is the Stock a Buy?

…

Vertex Pharmaceuticals May Be About to Solve a Common Health Problem. Is the Stock a Buy?

Vertex shares recently reached an all-time high.…

Vertex Pharmaceuticals May Be About to Solve a Common Health Problem. Is the Stock a Buy? @themotleyfool #stocks $VRTX

Vertex shares recently reached an all-time high.…

These companies have earnings momentum heading into their reports next week

Analysts have grown increasingly bullish on Vertex Pharmaceuticals and Uber, among other companies that will issue their latest financials next…

Vertex Pharmaceuticals: Kursziel um 50 USD angepasst

New York (www.aktiencheck.de) - Rating-Update: Die Analysten von Oppenheimer belassen die Aktie von Vertex Pharmaceuticals Inc. (ISIN: US92532F1003, WKN: 882807, Ticker-Symbol:…

Vertex Pharmaceuticals abgestuft

New York (www.aktiencheck.de) - Rating-Update: Das Investmenthaus Maxim Group streicht seine Kaufempfehlung für die Aktie von Vertex Pharmaceuticals Inc. (ISIN: US92532F1003,…

Vertex Pharmaceuticals: Kursziel erhöht

Charlotte, NC (www.aktiencheck.de) - Rating-Update: Die Analysten von Truist belassen die Aktie des amerikanischen Biotech-Riesen Vertex Pharmaceuticals Inc. (ISIN: US92532F1003, WKN:…

Vertex Pharmaceuticals: Der Teufel steckt im Detail - Aktienanalyse

Kulmbach (www.aktiencheck.de) - Vertex Pharmaceuticals-Aktienanalyse von "Der Aktionär": Michel Doepke vom Anlegermagazin "Der Aktionär" nimmt in einer aktuellen Aktienanalyse die Aktie…

Solvias führt Freigabetests für die weltweit erste CRISPR-basierte Gen-Editierungstherapie durch

Solvias: Kaiseraugst, Schweiz (ots/PRNewswire) - Globaler Anbieter unterzeichnet langfristiges Abkommen mit Vertex Pharmaceuticals für CASGEVY™ Solvias, ein globaler Anbieter von…

Pro Research: Wall Street delves into Vertex Pharmaceuticals By Investing.com

Pro Research: Wall Street delves into Vertex Pharmaceuticals…

If You Invested $10,000 in Vertex Pharmaceuticals in 2018, This Is How Much You Would Have Today

Has investing in Vertex been a better option than just putting your money in the S&P 500?…

If You Invested $10,000 in Vertex Pharmaceuticals in 2018, This Is How Much You Would Have Today @themotleyfool #stocks $VRTX $CRSP

Has investing in Vertex been a better option than just putting your money in the S&P 500?…

dpa-AFX ProFeed